Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Rutkowski

Showing results (1-10 of 491) with videos related to

Pageof 50
Sort By:
Archives of Medical Science : AMS|December 2, 2022
The greatest achievements in oncology in 2022 - melanoma and skin carcinomasPiotr Rutkowski
Annals of Surgical Oncology|February 24, 2021
Why We Still Need the Better Risk Classification for GISTPiotr Rutkowski
The Lancet. Oncology|August 20, 2021
Antiangiogenic agents combined with systemic chemotherapy in refractory osteosarcomaPiotr Rutkowski
Melanoma Management|September 8, 2018
What is new in melanoma after European Cancer Congress 2017?Piotr Rutkowski
Waste Management (New York, N.Y.)|September 2, 2009
Influence of zinc chloride addition on the chemical structure of bio-oil obtained during co-pyrolysis of wood/synthetic polymer blendsPiotr Rutkowski
The Oncologist|May 28, 2013
Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumorsPiotr Rutkowski, Alessandro Gronchi
Memo|August 5, 2014
Follow-up in melanoma patientsPiotr Rutkowski, Iwona Lugowska
Memo|August 5, 2014
Follow-up in soft tissue sarcomasPiotr Rutkowski, Iwona Lugowska
Virchows Archiv : an International Journal of Pathology|December 16, 2018
Rational combination of cancer immunotherapy in melanomaMario Mandalà, Piotr Rutkowski
Expert Opinion on Drug Safety|July 12, 2014
Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluationPiotr Rutkowski, Christian Blank
Pageof 50

Showing results (1-10 of 491) with videos related to

Sort By:
Pageof 50
Archives of Medical Science : AMS|December 2, 2022
The greatest achievements in oncology in 2022 - melanoma and skin carcinomasPiotr Rutkowski
Annals of Surgical Oncology|February 24, 2021
Why We Still Need the Better Risk Classification for GISTPiotr Rutkowski
The Lancet. Oncology|August 20, 2021
Antiangiogenic agents combined with systemic chemotherapy in refractory osteosarcomaPiotr Rutkowski
Melanoma Management|September 8, 2018
What is new in melanoma after European Cancer Congress 2017?Piotr Rutkowski
Waste Management (New York, N.Y.)|September 2, 2009
Influence of zinc chloride addition on the chemical structure of bio-oil obtained during co-pyrolysis of wood/synthetic polymer blendsPiotr Rutkowski
The Oncologist|May 28, 2013
Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumorsPiotr Rutkowski, Alessandro Gronchi
Memo|August 5, 2014
Follow-up in melanoma patientsPiotr Rutkowski, Iwona Lugowska
Memo|August 5, 2014
Follow-up in soft tissue sarcomasPiotr Rutkowski, Iwona Lugowska
Virchows Archiv : an International Journal of Pathology|December 16, 2018
Rational combination of cancer immunotherapy in melanomaMario Mandalà, Piotr Rutkowski
Expert Opinion on Drug Safety|July 12, 2014
Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluationPiotr Rutkowski, Christian Blank
Pageof 50